Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Joshua Meyer

Email
Center AffiliationsMolecular Therapeutics

Publications (65) (print view)

no pagination
Shaikh T, Churilla T, Murphy C, Zaorsky NG, Haber A, Hallman M, Meyer JE. 97O: Overtreatment of patients with clinically diagnosed early stage lung cancer. J Thorac Oncol. 2016 Apr;11(4 Suppl):S99.
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer. Practical radiation oncology. 2016 Jul;6(4):e107-15.
Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Shields A, Philip P, Meyer JE. Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer. Acta Oncol. 2016 Mar;55(3):303-8.
Yoon S, Shaikh T, Ross EA, Bauman J, Borghaei H, Mehra R, Meyer JE, Hallman MA. Patterns and Predictors of Failure Following Definitive Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E477-E478.
Zaorsky NG, Shaikh T, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE. What Are Medical Students in the United States Learning About Radiation Oncology? Results of a Multi-Institutional Survey. International Journal of Radiation Oncology Biology Physics. 2016 Feb;94(2):235-42.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf PL, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: A systematic review. Cancer Treat Rev. 2016 Dec 22;53:47-52.
Price R, Meyer J, Horwitz E, Ma C. SU-E-T-747: The Use of the EQD2 Formalism and Repair Estimates in the Re-Irradiation Setting and Correlation with Patient Follow-Up Data. Med Phys. 2015 Jun;42(6):3508.
Shaikh T, Ruth K, Scott WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer. Ann Thorac Surg. 2015 Jan;99(1):270-6.
Shaikh T, Ruth K, Scott WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE. Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer. Ann Thorac Surg. 2015 Jan;99(1):270-6.   PMCID: PMC4284823
Shaikh T, Thomay A, Ruth K, Cohen SJ, Meyer JE. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer. Journal of surgical oncology. 2015 Nov;112(6):629-33.
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2015 Aug 28;.   PMCID: 4769977
Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015 Dec 22;6(41):43594-604.   PMCID: PMC4791253
Smaglo BG, Tesfaye A, Halfdanarson TR, Meyer JE, Wang J, Gatalica Z, Reddy S, Arguello D, Boland PM. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015 Oct 20;6(41):43594-604.
Veltchev I, Fourkal E, Doss M, Yu J, Meyer J, Ma C. SU-F-BRA-15: Physical Aspects and Clinical Applications of Post-Treatment Yttrium-90 PET-Based Dosimetry. Med Phys. 2015 Jun;42(6):3537.
Wang LS, Shaikh T, Handorf EA, Hoffman JP, Cohen SJ, Meyer JE. Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Practical radiation oncology. 2015 Sep;5(5):e457-63.   PMCID: 4814166
Chen KT, Devarajan K, Milestone BN, Cooper HS, Denlinger C, Cohen SJ, Meyer JE, Hoffman JP. Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?. Annals of Surgical Oncology. 2014 Feb;21(2):662-9.
Cohen SJ, Konski AA, Putnam S, Ball DS, Meyer JE, Yu JQ, Astsaturov I, Marlow C, Dickens A, Cade DN, Meropol NJ. Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer. Br J Cancer. 2014 Jul 15;111(2):265-71.   PMCID: Pmc4102951
Hurwitz MD, Ghanouni P, Kanaev SV, Iozeffi D, Gianfelice D, Fennessy FM, Kuten A, Meyer JE, LeBlang SD, Roberts A, Choi J, Larner JM, Napoli A, Turkevich VG, Inbar Y, Tempany CM, Pfeffer RM. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results. Journal of the National Cancer Institute. 2014 May;106(5).   PMCID: 4112926
Konski A, Meyer JE, Joiner M, Hall MJ, Philip P, Shields A, McSpadden E, Choi M, Adaire B, Duncan G, Meropol NJ, Cescon TP, Cohen SJ. Multi-institutional phase I study of low-dose ultra-fractionated radiotherapy as a chemosensitizer for gemcitabine and erlotinib in patients with locally advanced or limited metastatic pancreatic cancer. Radiother Oncol. 2014 Oct;113(1):35-40.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Joshua Meyer Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Monday, November 04, 2019